Live Breaking News & Updates on Yuexing Su

Stay updated with breaking news from Yuexing su. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Asia Major: Investors back CN Bio's $21m Series B first close

VC investors from China and Hong Kong have backed the first close of a $21 million Series B round for Cambridge-based Life Science company CN Bio. Beijing-based Bayland Capital and founding shareholder CN Innovations Holdings Ltd from Hong Kong are to invest $10m and $5.5m, respectively. Other serial backers have reinvested. ....

Hong Kong , United Kingdom , Charles Chong , Yuexing Su , Cn Innovations Holdings Ltd , Beijing Based Bayland Capital , Holdings Ltd , Paul Brooks , Bayland Capital , Founding Partner , Managing Director ,

CN Bio Raises $21 Million USD in First Close of Series B Investment Round

CN Bio Raises $21 Million USD in First Close of Series B Investment Round
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , Acta Pharmaceutica Sinica , Yuexing Su , Dennis Riedl , Charles Chong , Lily Jeffery , Cn Innovations Holdings Ltd , Zyme Communications , Bayland Capital , Holdings Ltd , Paul Brooks , Founding Partner , Managing Director , Aktien Sie ,

CN Bio raises $21 million to scale up organ-on-a-chip technology

CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions. ....

United Kingdom , Charles Chong , Yuexing Su , Bio Physiomimix , Altis Biosystems , Bayland Capital , Alti Repligut Planar Jejunum ,